Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

GLP1 RA | Image credit: Patrick Bay Damsted - stock.adobe.com

GLP-1 Receptor Agonists Unlikely to Increase Risk of Suicide-Related Events

By Pearl Steinzor

March 20th 2025

A meta-analysis finds no significant increase in suicide-related events with glucagon-like peptide-1 receptor agonists.

A recent move by the Trump administration cancelled $400 million in funding, a lot of which was crucial for ongoing scientific and medical research. | image credit: lexiconimages - stock.adobe.com

Trump Administration Cancels Crucial Funding for Diabetes Prevention Program

By Kyle Munz

March 18th 2025

Female patient and doctor - Dragana Gordic - stock.adobe.com.jpeg

Poor Patient-Clinician Communication Linked to Diabetes Care Delays

By Pearl Steinzor

March 14th 2025

Woman asleep at desk - fizkes - stock.adobe.com.jpeg

Poor Sleep Tied to Higher Type 2 Diabetes Risk in Women With Gestational Diabetes

By Pearl Steinzor

March 10th 2025

Real-World Digitally Based Diabetes Management Program Implementation by a Large Employer

By Jean M. Abraham, PhD
Teresa Ambroz, MPH, RDN

March 4th 2025

More News

February 23rd 2022

Jill Hutt Outlines the GPBCH's Work With the National Diabetes Prevention Program

Gianna Melillo

Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health (GPBCH), describes how the organization first became involved with the National Diabetes Prevention Program.

February 14th 2022

NCCC Releases Recommendations to Improve Federal Response to Diabetes Epidemic

Gianna Melillo

The National Clinical Care Commission (NCCC) issued 39 recommendations to improve diabetes prevention and care in the United States.

February 13th 2022

Contributor: How Payers Are Applying AI to Solve the Problem of Incomplete Data—3 Use Cases

Calum Yacoubian, MD

In this column, Calum Yacoubian, MD, outlines how artificial intelligence, specifically, natural language processing, can help address gaps in patient data.

February 11th 2022

Dr Robert Gabbay on the Intersection of COVID-19 and Diabetes

Gianna Melillo Skylar Jeremias

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, shares his thoughts on long COVID-19 among those with type 2 diabetes and the rise of new-onset cases of type 1 diabetes throughout the pandemic.

February 8th 2022

SURPASS-5 Data: Tirzepatide Plus Insulin Glargine Improve Glycemic Control in T2D

Gianna Melillo

Data from SURPASS-5 show Eli Lilly's glucagon-like peptide-1 receptor agonist tirzepatide helped improve glycemic control when taken with insulin glargine.

February 2nd 2022

Dr Robert Gabbay Discusses Management of Pediatric Type 1, 2 Diabetes

Gianna Melillo Skylar Jeremias

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses some of the challenges of treating pediatric patients with type 1 or type 2 diabetes.

January 31st 2022

Insulet's Omnipod 5 Cleared by FDA

Gianna Melillo

The FDA has cleared the first tubeless automated insulin delivery system with a smartphone app control.

January 25th 2022

Increases in Pediatric T1D Incidence Seen During COVID-19

Gianna Melillo

Findings from 2 studies conducted among German and US children highlight the growing incidence of type 1 diabetes (T1D) among children throughout the COVID-19 pandemic.

January 23rd 2022

Contributor: Empowering Endocrinologists With Technology for the Diagnosis, Management, and Treatment of NAFLD

Juan Pablo Frias, MD

In this column, an endocrinologist discusses the growing problem of liver disease and new options at their disposal, including vibration-controlled transient elastography.

January 19th 2022

SDOH-Induced Changes to Gut Microbiome Could Contribute to Racial Disparities in T2D

Gianna Melillo

Findings of a pilot study suggest that gut microbiome differences resulting from environmental factors could affect racial disparities in type 2 diabetes.

January 17th 2022

Diabetes Medication Costs, Utilization Differed by Medicaid or Marketplace Enrollment

Gianna Melillo

New data show that Medicaid enrollees with diabetes in Colorado have greater access to new medications and incur less associated costs compared with patients with Marketplace plans.

January 12th 2022

Decrease in Diabetes All-Cause Mortality Seen in High-Income Countries

Gianna Melillo

New data revealed that rates of all-cause mortality among those with diabetes decreased between 1995 and 2016 in high-income countries.

January 10th 2022

Researchers Propose Model to Replicate Patient Experience in Artificial Pancreas System

Lauren Massaro

A methodology to monitor patient-in-the-loop modes and faults was examined using a hybrid automata model that was able to replicate patient’s real-life operation modes.

January 8th 2022

Review: Commercially Developed, Open-Source AID Systems Deemed Safe and Effective

Lauren Massaro Gianna Melillo

Gleaning data from real-world studies, investigators determined that commercially developed and open-source automated insulin dosing systems are safe and effective.

January 5th 2022

Study Supports Call for Geographically Tailored Diabetes Care Interventions

Gianna Melillo

Patients with diabetes living in rural or deprived regions in the United States are less likely to achieve optimal care for their condition, according to a new cross-sectional study.

December 30th 2021

Top 5 Most-Read Type 1 Diabetes Articles of 2021

Gianna Melillo

December 27th 2021

Analysis Highlights Disparities in GLP-1 RA Access

Gianna Melillo

An analysis uncovered racial, ethnic, and socioeconomic inequities regarding access to glucagon-like peptide-1 receptor agonists among US patients with diabetes.

December 23rd 2021

Family History of T2D May Increase MACE Risk in Those With T1D

Gianna Melillo

A study carried out in Taiwan found that a family history of type 2 diabetes (T2D) may increase the risks of diabetes-related complications in those with type 1 diabetes (T1D).

December 20th 2021

Top 5 Most-Read Diabetes Articles of 2021

Gianna Melillo

New research on semaglutide and empagliflozin appear on this year’s list of most-read diabetes articles.

December 15th 2021

Study: Racial-Ethnic Disparities in T1D Technology Use Worsened From 2017 to 2019

Gianna Melillo

Between coverage years 2017 and 2019, racial-ethnic disparities in diabetes technology use worsened among Medicare beneficiaries with type 1 diabetes.

December 8th 2021

Experts Examine the Association Between Retinal Damage, DKD Presence in Patients With T2D

Gianna Melillo

Results of a cross-sectional study fond diabetic kidney disease (DKD) was associated with retinal changes in patients with type 2 diabetes (T2D).

December 6th 2021

Review: Smartphone Apps May Improve Outcomes in Gestational Diabetes

Gianna Melillo

Results of a systemic review found evidence potentially supporting the use of smart phone applications among mothers with gestational diabetes.

December 1st 2021

Does Gender-Affirming Hormone Therapy Affect T2D Risk?

Gianna Melillo

Results of a cohort study showed that transfeminine individuals may be at a higher risk for type 2 diabetes (T2D) compared with cisgender females, but revealed little evidence that gender-affirming hormone therapy impacts diabetes risk.

November 29th 2021

Variability in Statin Use Seen Among Finnish T2D Population

Gianna Melillo

Data showed differences in statin use to prevent cardiovascular disease among Finnish patients with type 2 diabetes.

November 22nd 2021

Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now?

Jordan Messler, MD, SFHM, FACP

CMS' introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec.

November 16th 2021

Dr Robert Gabbay Outlines How the Health Equity Now Initiative Addresses Diabetes Care Disparities

Hayden E. Klein

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, explains the Health Equity Now initiative and how it shines a light on health disparities.

November 10th 2021

Dr Robert Gabbay on COVID-19 Vaccinations in the Diabetes Community

Hayden E. Klein

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses COVID-19 vaccinations among people with diabetes as they have been disproportionally affected by the pandemic.

November 10th 2021

Challenges With Implementing the Diabetes Prevention Program for Medicare Beneficiaries in an Integrated Health System

Inga Gruß, PhD Alison Firemark, MA Dea Papajorgji-Taylor, MPH Stephanie L. Fitzpatrick, PhD

This study presents challenges of implementing the CDC-approved Diabetes Prevention Program for Medicare beneficiaries at a large, integrated health care delivery system.

November 8th 2021

Analysis Details Factors Associated With T2D Development Among Women With PCOS

Gianna Melillo

Results of a cross-sectional study detail characteristics among women with polycystic ovary syndrome (PCOS) who develop type 2 diabetes.

November 3rd 2021

Study Evaluates Impact of Food Environments on T2D Risk

Gianna Melillo

Results of a longitudinal study indicate community food accessibility factors may impact type 2 diabetes risk among veterans.

...

5 6 7 8 9 10 11 12 13

...

97 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions